Confluence Wealth Services’s Krystal Biotech KRYS Stock Holding History

Confluence Wealth Services’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Buy	3,792 +870	+30%	+$260K	0.04%	193
2026 Q1	$755K	Hold	2,922	–	–	0.03%	222
2025 Q4	$720K	Hold	2,922	–	–	0.03%	223
2025 Q3	$516K	Hold	2,922	–	–	0.03%	239
2025 Q2	$402K	Buy	2,922 +2	+0.1%	+$294	0.02%	272
2025 Q1	$484K	Hold	2,920	–	–	0.03%	233
2024 Q4	$453K	Hold	2,920	–	–	0.03%	233
2024 Q3	$532K	Hold	2,920	–	–	0.04%	215
2024 Q2	$536K	Hold	2,920	–	–	0.04%	217
2024 Q1	$520K	Hold	2,920	–	–	0.05%	204
2023 Q4	$362K	Hold	2,920	–	–	0.04%	217
2023 Q3	$339K	Buy	2,920 +500	+21%	+$61K	0.07%	197
2023 Q2	$284K	Buy	+2,420	New	+$247K	0.06%	221
2022 Q1	–	Sell	-370	Closed	-$25K	–	733
2021 Q4	$25K	Buy	+370	New	+$21.5K	0.01%	670

Other funds holding KRYS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Confluence Wealth Services's KRYS Position: Q2 2026 in Review

Confluence Wealth Services increased its Krystal Biotech (KRYS) stake by 30% in Q2 2026, buying an estimated $260K and bringing the position to 3,792 shares worth $1.41M. The position accounts for 0.04% of the portfolio, ranked #193.

Confluence Wealth Services first reported a position in KRYS in Q4 2021 and has held it in 14 quarters since. 74 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Confluence Wealth Services held 3,792 shares of Krystal Biotech worth $1.41M as of Q2 2026.
Confluence Wealth Services bought 870 Krystal Biotech shares in Q2 2026, an estimated $260K.
Krystal Biotech made up 0.04% of Confluence Wealth Services's portfolio in Q2 2026, its #193 holding.
Confluence Wealth Services first reported a position in Krystal Biotech in Q4 2021 and has held it in 14 quarters since.
74 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.